Detailed GuideMHRA
Comparator products in bioequivalence/therapeutic equivalence studies
Information on comparator products used in studies supporting abridged marketing authorisation application.
First published: Dec 31, 2020Last updated: Dec 20, 2024Changes: 2
Latest change: Added section numbers and document overview. Updated all sections for clarity and territorial changes – GB revised to UK. Updated references to applicable regulations. Updated section 3.2 list of acceptable regulator countries. Updated section 4 contact details
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.